Background: Diabetes mellitus causes changes in the structural or functional anatomy of the heart. A high blood glucose level and oxidative stress are key factors in diabetic cardiac damage. Ferulic acid (4-hydroxy-3-methoxy cinnamic acid) is a biologically active compound in many functional foods like fruits, vegetables, and medicinal herbs. It belongs to the group of cinnamic acid derivatives.Objective: In the present study, we investigated the effects of Ferulic acid (FA) on Streptozotocin-induced diabetic cardiac damage in male Sprague Dawley rats.Materials and methods: A total of 30 male Sprague-Dawley rats were divided into five groups of six each. Diabetes was induced by a single intraperitoneal injection of Streptozotocin (STZ) (40 mg/kg body weight). Group I consisted of normal rats (N); group II consisted of normal rats treated with FA (N+FA); group III consisted of STZ-induced diabetic rats (D), and groups IV and V consisted of STZ-induced diabetic rats treated with FA at a dose of 50 mg/kg body weight and glibenclamide at a dose of 5 mg/kg body weight respectively (N+FA and N+G) for 60 days. Rats were sacrificed after the treatment period, and blood and heart tissue were collected for analysis.Results: STZ injection significantly increased blood glucose, HbA1c, cardiac marker enzymes LDH, CK-MB, and oxidative stress in heart tissue. The oral administration of FA to diabetic rats for 60 days significantly improved diabetic markers, oxidative stress, and cardiac markers.Conclusion: The present study indicated that FA affords cardioprotective effect in diabetic rats, and this protection may be due in part to the attenuation of oxidative stress.Keywords: ferulic acid, streptozotocin, diabetes, cardiac damage, oxidative stress
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.